Baudax Bio to Present at the 24th Annual H.C. Wainwright Healthcare Conference

Rhea-AI Summary

MALVERN, Pa., Sept. 8, 2022 – Baudax Bio (NASDAQ:BXRX) announced that CEO Gerri Henwood will present at the 24th Annual H.C. Wainwright Healthcare Conference on September 14, 2022, at 3:00 p.m. ET in New York. Investors can access a webcast of the presentation on the company's website, which will be archived for 90 days. Baudax Bio focuses on innovative acute care products, notably ANJESO®, a non-opioid IV NSAID for managing severe pain. The company has a pipeline that includes novel neuromuscular blocking agents and a chemical reversal agent.

MALVERN, Pa., Sept. 08, 2022 (GLOBE NEWSWIRE) -- Baudax Bio, Inc. (NASDAQ:BXRX), a pharmaceutical company focused on innovative products for acute care settings, today announced that Gerri Henwood, the Company’s President and Chief Executive Officer, will present at the 24^th Annual H.C. Wainwright Healthcare Conference, taking place in New York, New York on Wednesday, September 14, 2022 at 3:00 p.m. Eastern Time.

A webcast of the presentation will be available on the “Events” page within the investors section of the Baudax Bio website at https://www.baudaxbio.com/news-and-investors. The webcast will be archived on the company’s website for 90 days following the event.

About Baudax Bio

Baudax Bio is a pharmaceutical company focused on innovative products for acute care settings. Baudax Bio markets ANJESO®, the first and only 24-hour, non-opioid, intravenous (IV) COX-2 preferential non-steroidal anti-inflammatory (NSAID) for the management of moderate to severe pain. In addition to ANJESO, Baudax Bio has a pipeline of other innovative pharmaceutical assets including two clinical-stage, novel neuromuscular blocking agents (NMBs) and a proprietary chemical reversal agent specific to these NMBs. For more information, please visit www.baudaxbio.com.

CONTACT:

Investor Relations Contact:

Argot Partners
Sam Martin / Kaela Ilami
(212) 600-1902
baudaxbio@argotpartners.com

Media Contact:

Argot Partners
David Rosen
(212) 600-1902
david.rosen@argotpartners.com

FAQ

When is Baudax Bio's presentation at the H.C. Wainwright Healthcare Conference?

Baudax Bio will present on September 14, 2022, at 3:00 p.m. Eastern Time.

Where can I watch the Baudax Bio conference presentation?

The presentation can be accessed via a webcast on Baudax Bio's website under the investors section.

What is ANJESO® by Baudax Bio?

ANJESO® is the first non-opioid intravenous COX-2 preferential NSAID for managing moderate to severe pain.

What innovative products does Baudax Bio have in its pipeline?

Baudax Bio's pipeline includes clinical-stage neuromuscular blocking agents and a proprietary chemical reversal agent.

How long will the Baudax Bio presentation webcast be available?

The archived webcast will be available for 90 days after the event.